Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin DDI with Simvastatin in Healthy Volunteers
NCT05306379Phase 1Completed
- Sponsor
- Aurinia
- Start
- Jan 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of voclosporin in lupus nephritis (LN), sponsored by Aurinia. Primary endpoints: Pharmacokinetics of simvastatin and simvastatin acid (Cmax) at 9 days and Pharmacokinetics of simvastatin and simvastatin acid (AUC) at 9 days. Started Jan 2022; status: completed.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05306379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05306379.